But it also means more injections, more complex dosing schedules, and more potential drug interactions
Alpha & Eden BPC-157 is supplied as a high-purity lyophilized powder for controlled research applications
Despite the recognition of obesity as a major healthcare threat and the implementation of interventions including lifestyle modification, first-generation obesity pharmacotherapy, and bariatric surgery [9], the prevalence of obesity continued to rise significantly for decades up until 2023 [10]
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study
Bottom line: BPC-157 is an investigational compound with a compelling preclinical profile and growing practitioner adoption
It also has a longer track record, gastric sleeve and gastric bypass outcomes have been studied for decades